ACACA and psoriasis: Therefore, to explore the clinical potential of ACC1 inhibition in inflammatory skin disease, in the future, we plan to investigate the use of topical inhibitors of ACC1 such as Soraphen A (SorA) [24] and its effects on human T cells isolated from psoriasis patients.